Report Code: A13346 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Glucose tolerance test is a diagnostic mechanism to measure body’s response to changes in sugar levels, thus, it can be used to diagnose diabetes. The test is known as oral glucose tolerance test (OGTT). The procedure involves a normal blood test as part of pilot study. Post this, the patient is asked to drink a liquid containing glucose. Subsequently, the blood test is carried out again to contemplate changes is blood glucose level. Higher glucose level signals non-absorption of sugar by body cells. Glucose challenge test is the short version of glucose tolerance test. It involves drinking concentrated glucose solution and subsequent blood test to contemplate blood sugar levels.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
At the early phase of the COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global markets. These players achieved an edge over other diagnostics players capitalizing on the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
Owing to such factors, COVID 19 is expected to have a significant impact on the global glucose tolerance test market.
Top Impacting Factors
Key Market Trends
Key Benefits of the Report
Questions Answered in the Global Glucose Tolerance Test Report
Glucose Tolerance Test Market Report Highlights
Aspects | Details |
---|---|
By Product Type |
|
By Disease Indication |
|
By End User |
|
By Region |
|
Key Market Players | Thermo Fisher Scientific Inc., F.Hoffman-La Roche Ltd., Medtronic Inc, Sanofi, Abbott Labs, Merck KGaA, Panasonic, Penlan Healthcare Ltd., Lifescan IP Holdings, Bayer AG, E-Zlab Health Services, ARUP Labs, Quest Diagnostics Incorporated, Dexcom, Inc., Trividia Health Inc., Cleveland Heartlab Inc, Ascensia Diabetes Care Holdings AG, Laboratory Corporation of American Holdings, Johnson and Johnson Inc |
Loading Table Of Content...
Start reading.
This Report and over 71,295+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers